News
![Removal of Ranitidine from Market](https://www.carlisleandassociates.net/wp-content/uploads/2020/04/Removal-of-Ranitidine-from-Market.jpg)
Removal of Ranitidine from Market
The Food and Drug Administration (FDA) recently announced a request for manufacturers to remove all…
Apr 15, 2020
![First-Time Generic Release of Vimovo](https://www.carlisleandassociates.net/wp-content/uploads/2020/03/First-Time-Generic-Release-of-Vimovo.jpg)
First-Time Generic Release of Vimovo
The generic equivalent of Vimovo (naproxen/esomeprazole) is now available. Vimovo is FDA approved for the…
Mar 09, 2020
![FDA Releases Warning Regarding Gabapentin and Pregabalin](https://www.carlisleandassociates.net/wp-content/uploads/2019/12/FDA-Releases-Warning-Regarding-Gabapentin-and-Pregabalin.jpg)
FDA Releases Warning Regarding Gabapentin and Pregabalin
The FDA recently released a warning for the medications, gabapentin (Neurontin, Gralise, Horizant) and pregabalin…
Dec 23, 2019
![FDA Alert Concerning Ranitidine Products](https://www.carlisleandassociates.net/wp-content/uploads/2019/09/FDA-Alert-Concerning-Ranitidine-Products.jpg)
FDA Alert Concerning Ranitidine Products
By: Heidi Dufrene, Pharmacy Director Earlier this month, the U.S. Food and Drug Administration (FDA)…
Sep 25, 2019